Table 3.
Molding Conditions Used for the Indirect Stereolithography Technology with Various Biomaterials to Construct Unipore Scaffolds
| |
|
Hardening process |
Mold removal |
||
|---|---|---|---|---|---|
| Material | Preparation of injectable biomaterial | Method dipping process | Time (h) | NaOH (N) | Time (h) |
| PCL | Chloroform/75% w/v | Solvent/nonsolvent exchange (isopropanol) | 24 | 1 | 6 |
| PLLA | Chloroform/25% w/v | Solvent/nonsolvent exchange (isopropanol) | 12 (−80°C)/24 | 0.2 | 8 (0°C) |
| PLGA | Chloroform/75% w/v | Solvent/nonsolvent exchange (isopropanol) | 12 (−80°C)/24 | 0.2 | 8 (0°C) |
| Chitosan | 1 N Acetic acid/5% w/v | 1 N NaOH | 0.5 | 1 | 6 |
| Alginate | Distilled water/6% w/v | 5% w/v CaCl2 | 3 | 1 | 6 |
| Bone cement | Mixing powder and liquid | Self-hardening | 0.1 | 1 | 6 |
Undefined process temperature is room temperature.